Onuchic, Ana Claudia; Machado, Camila M. L.; Saito, Renata F.; Rios, Francisco J.; Jancar, Sonia 
; Chammas, Roger
Source: Mediators of Inflammation. Unidade: FM
Subjects: WESTERN BLOTTING, CITOMETRIA DE FLUXO, ESTRESSE OXIDATIVO, FATOR DE ATIVAÇÃO DE PLAQUETAS, MELANOMA (QUIMIOTERAPIA), PROGNÓSTICO, TERAPIA COMBINADA, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ONUCHIC, Ana Claudia et al. Expression of PAFR as Part of a Prosurvival Response to Chemotherapy: A Novel Target for Combination Therapy in Melanoma. Mediators of Inflammation, v. 2012, p. 1-6, 2012Tradução . . Disponível em: https://doi.org/10.1155/2012/175408. Acesso em: 04 nov. 2024.APA
Onuchic, A. C., Machado, C. M. L., Saito, R. F., Rios, F. J., Jancar, S., & Chammas, R. (2012). Expression of PAFR as Part of a Prosurvival Response to Chemotherapy: A Novel Target for Combination Therapy in Melanoma. Mediators of Inflammation, 2012, 1-6. doi:10.1155/2012/175408NLM
Onuchic AC, Machado CML, Saito RF, Rios FJ, Jancar S, Chammas R. Expression of PAFR as Part of a Prosurvival Response to Chemotherapy: A Novel Target for Combination Therapy in Melanoma [Internet]. Mediators of Inflammation. 2012 ; 2012 1-6.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1155/2012/175408Vancouver
Onuchic AC, Machado CML, Saito RF, Rios FJ, Jancar S, Chammas R. Expression of PAFR as Part of a Prosurvival Response to Chemotherapy: A Novel Target for Combination Therapy in Melanoma [Internet]. Mediators of Inflammation. 2012 ; 2012 1-6.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1155/2012/175408
